| Diana Dawn Simmons, FNP-C APN | |
|
530 Ne Glen Oak Ave, Peoria, IL 61637-0001 | |
| (309) 624-4945 | |
| (309) 624-9848 |
| Full Name | Diana Dawn Simmons |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 530 Ne Glen Oak Ave, Peoria, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033669817 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 209014648 (Illinois) | Primary |
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured.
The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.
Being overweight and obese during adolescence appears related to an increased risk of all-cause treated end-stage renal disease (ESRD) during a 25-year period, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
Novartis announced today that the US Food and Drug Administration has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).
› Verified 1 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured.
The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.
Being overweight and obese during adolescence appears related to an increased risk of all-cause treated end-stage renal disease (ESRD) during a 25-year period, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
Novartis announced today that the US Food and Drug Administration has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diana Dawn Simmons, FNP-C APN 530 Ne Glen Oak Ave, Peoria, IL 61637-0001 Ph: (309) 624-4945 | Diana Dawn Simmons, FNP-C APN 530 Ne Glen Oak Ave, Peoria, IL 61637-0001 Ph: (309) 624-4945 |
News Archive
Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured.
The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis of the lungs.
Being overweight and obese during adolescence appears related to an increased risk of all-cause treated end-stage renal disease (ESRD) during a 25-year period, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
Novartis announced today that the US Food and Drug Administration has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).
› Verified 1 days ago
Mr. Ryan Eugene Parnham, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 530 Ne Glen Oak Ave, Suite 108, Peoria, IL 61537 Phone: 309-624-8818 | |
Faye Yetton, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2015 W Austin Dr, Peoria, IL 61614 Phone: 309-256-0632 | |
Linda Schmidgall, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 420 Ne Glen Oak Ave, Suite 200, Peoria, IL 61603 Phone: 309-624-5100 Fax: 309-624-5569 | |
Sandra L. Peach, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 420 Ne Glen Oak Ave, Peoria, IL 61603 Phone: 309-655-2343 Fax: 309-655-3948 | |
Roxanne Mclaughlin, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8940 N Wood Sage Rd, Peoria, IL 61615 Phone: 309-243-3000 Fax: 309-243-3274 | |
Suzanne D Tietjen, BSN, NNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-2974 | |
Brittany N Hemmele, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8600 N State Route 91, Peoria, IL 61615 Phone: 309-683-5050 Fax: 309-683-5335 |